The Vox Markets Podcast / Greg Madison of Shield Therapeutics: “There is a very substantial market opportunity for Accrufer®”

View our embed guidelines

Sorry, your browser isn't supported by Audioboom.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.